Munshi Amit

SEC CIK: 0001612551

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

IKT Inhibikase Therapeutics, Inc.Directoras of Jun 30, 2026
ZURA Zura Bio LtdDirectoras of Jun 22, 2026
ARQT Arcutis Biotherapeutics, Inc.Directoras of Jun 9, 2026
DMRA Damora Therapeutics, Inc.Directoras of Jun 20, 2025
ARNA Arena Pharmaceuticals IncPresident and CEOas of Mar 11, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists Munshi Amit as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

IKT Inhibikase Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Oct 23, 2024 (view filing)	Oct 21	2 days	Munshi AmitDirector	PPurchase	+365.0K	$1.37	+$500.1K	New position365.0K after

ZURA Zura Bio Ltd